CASI
CASI Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
2.89 / 10Overall Score
UnderperformInvestment Rating
2.89 / 10Overall Score
UnderperformInvestment Rating
Is CASI a Good Buy Right Now?
- Based on a composite score of 2.89/10, we rate CASI as a Underperform. Our analysis breaks down into 2.36/10 for Fundamentals, 1.19/10 for Technicals, and 4.00/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Technical Analysis of CASI?
Is CASI undervalued or overvalued?
Is money flowing into or out of CASI?
Is CASI a Good Buy Right Now?
- Based on a composite score of 2.89/10, we rate CASI as a Underperform. Our analysis breaks down into 2.36/10 for Fundamentals, 1.19/10 for Technicals, and 4.00/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Is CASI undervalued or overvalued?
Technical Analysis of CASI?
Is money flowing into or out of CASI?
